Smart pH-responsive nanomedicines for disease therapy

• Published in: Journal of pharmaceutical investigation Vol. 52; no. 4; pp. 427 - 441
• Main Authors: Shinn, Jongyoon, Kwon, Nuri, Lee, Seon Ah, Lee, Yonghyun
• Format: Journal Article
• Language: English
• Published: Singapore Springer Nature Singapore 01-07-2022; 한국약제학회
• Subjects: Biomedical and Life Sciences; Biomedicine; Review; 약학; Tumor microenvironment; pH-responsiveness; Endosomal escape; Nanomedicines
• ISSN: 2093-5552; 2093-6214
• DOI: 10.1007/s40005-022-00573-z

Background
Currently nanomedicines are the focus of attention from researchers and clinicians because of the successes of lipid-nanoparticles-based COVID-19 vaccines. Nanoparticles improve existing treatments by providing a number of advantages including protection of cargo molecules from external stresses, delivery of drugs to target tissues, and sustained drug release. To prevent premature release-related side effects, stable drug loading in nanoformulations is required, but the increased stability of the formulation could also lead to a poor drug-release profile at the target sites. Thus, researchers have exploited differences in a range of properties (e.g., enzyme levels, pH, levels of reduced glutathione, and reactive oxygen species) between non-target and target sites for site-specific release of drugs. Among these environmental stimuli, pH gradients have been widely used to design novel, responsive nanoparticles.
Area covered
In this review, we assess drug delivery based on pH-responsive nanoparticles at the levels of tissues (tumor microenvironment, pH ~ 6.5) and of intracellular compartments (endosome and lysosome, pH 4.5–6.5). Upon exposure to these pH stimuli, pH-responsive nanoparticles respond with physicochemical changes to their material structure and surface characteristics. These changes include swelling, dissociation, or surface charge switching, in a manner that favors drug release at the target site (the tumor microenvironment region and the cytosol followed by endosomal escape) rather than the surrounding tissues.
Expert opinion
Lastly, we consider the challenges involved in the development of pH-responsive nanomedicines.